\begin{thebibliography}{10}
\providecommand \doibase [0]{http://dx.doi.org/}%

\bibitem{Sully2013}
Sully BGO, Julious SA, Nicholl J. A reinvestigation of recruitment to
  randomised, controlled, multicenter trials: a review of trials funded by two
  UK funding agencies. {\it Trials} 2013\string; 14(1)\string: 166.
\newblock \href {\doibase 10.1186/1745-6215-14-166} {doi:
  10.1186/1745-6215-14-166}

\bibitem{Fay2006}
Fay MP, Halloran ME, Follmann DA. Accounting for Variability in Sample Size
  Estimation with Applications to Nonadherence and Estimation of Variance and
  Effect Size. {\it Biometrics} 2006\string; 63(2)\string: 465--474.
\newblock \href {\doibase 10.1111/j.1541-0420.2006.00703.x} {doi:
  10.1111/j.1541-0420.2006.00703.x}

\bibitem{Teare2014}
Teare M, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters S. Sample size
  requirements to estimate key design parameters from external pilot randomised
  controlled trials: a simulation study. {\it Trials} 2014\string;
  15(1)\string: 264.
\newblock \href {\doibase 10.1186/1745-6215-15-264} {doi:
  10.1186/1745-6215-15-264}

\bibitem{Eldridge2016}
Eldridge SM, Lancaster GA, Campbell MJ, et al. Defining Feasibility and Pilot
  Studies in Preparation for Randomised Controlled Trials: Development of a
  Conceptual Framework. {\it {PLOS} {ONE}} 2016\string; 11(3)\string: e0150205.
\newblock \href {\doibase 10.1371/journal.pone.0150205} {doi:
  10.1371/journal.pone.0150205}

\bibitem{Avery2017}
Avery KNL, Williamson PR, Gamble C, et al. Informing efficient randomised
  controlled trials: exploration of challenges in developing progression
  criteria for internal pilot studies. {\it {BMJ} Open} 2017\string;
  7(2)\string: e013537.
\newblock \href {\doibase 10.1136/bmjopen-2016-013537} {doi:
  10.1136/bmjopen-2016-013537}

\bibitem{Lancaster2004}
Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies:
  recommendations for good practice. {\it Journal of Evaluation in Clinical
  Practice} 2004\string; 10(2)\string: 307--312.
\newblock \href {\doibase 10.1111/j..2002.384.doc.x} {doi:
  10.1111/j..2002.384.doc.x}

\bibitem{Craig2008}
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing
  and evaluating complex interventions: the new Medical Research Council
  guidance. {\it BMJ: British Medical Journal} 2008\string; 337.
\newblock \href {\doibase 10.1136/bmj.a1655} {doi: 10.1136/bmj.a1655}

\bibitem{Arain2010}
Arain M, Campbell M, Cooper C, Lancaster G. What is a pilot or feasibility
  study? A review of current practice and editorial policy. {\it BMC Medical
  Research Methodology} 2010\string; 10(1)\string: 67.
\newblock \href {\doibase 10.1186/1471-2288-10-67} {doi:
  10.1186/1471-2288-10-67}

\bibitem{Thabane2010}
Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why and
  how. {\it BMC Medical Research Methodology} 2010\string; 10(1)\string: 1.
\newblock \href {\doibase 10.1186/1471-2288-10-1} {doi: 10.1186/1471-2288-10-1}

\bibitem{Eldridge2016a}
Eldridge SM, Chan CL, Campbell MJ, et al. {CONSORT} 2010~{s}tatement: extension
  to randomised pilot and feasibility trials. {\it {BMJ}} 2016\string: i5239.
\newblock \href {\doibase 10.1136/bmj.i5239} {doi: 10.1136/bmj.i5239}

\bibitem{Lancaster2015}
Lancaster GA. Pilot and feasibility studies come of age!. {\it Pilot and
  Feasibility Studies} 2015\string; 1(1)\string: 1.
\newblock \href {\doibase 10.1186/2055-5784-1-1} {doi: 10.1186/2055-5784-1-1}

\bibitem{Cooper2018}
Cooper CL, Whitehead A, Pottrill E, Julious SA, Walters SJ. Are pilot trials
  useful for predicting randomisation and attrition rates in definitive
  studies: A review of publicly funded trials. {\it Clinical Trials}
  2018\string; 0(0)\string: 1740774517752113.
\newblock PMID: 29361833\href {\doibase 10.1177/1740774517752113} {doi:
  10.1177/1740774517752113}

\bibitem{Eldridge2015}
Eldridge SM, Costelloe CE, Kahan BC, Lancaster GA, Kerry SM. How big should the
  pilot study for my cluster randomised trial be?. {\it Statistical Methods in
  Medical Research} 2015.
\newblock \href {\doibase 10.1177/0962280215588242} {doi:
  10.1177/0962280215588242}

\bibitem{NIHR2017}
{National Institute for Health Research} . Research for Patient Benefit (RfPB)
  Programme Guidance on Applying for Feasibility Studies. 2017.

\bibitem{Browne1995}
Browne RH. On the use of a pilot sample for sample size determination. {\it
  Statistics in Medicine} 1995\string; 14(17)\string: 1933--1940.
\newblock \href {\doibase 10.1002/sim.4780141709} {doi: 10.1002/sim.4780141709}

\bibitem{Julious2005}
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. {\it
  Pharmaceutical Statistics} 2005\string; 4(4)\string: 287--291.
\newblock \href {\doibase 10.1002/pst.185} {doi: 10.1002/pst.185}

\bibitem{Sim2012}
Sim J, Lewis M. The size of a pilot study for a clinical trial should be
  calculated in relation to considerations of precision and efficiency. {\it
  Journal of Clinical Epidemiology} 2012\string; 65(3)\string: 301--308.
\newblock \href {\doibase 10.1016/j.jclinepi.2011.07.011} {doi:
  10.1016/j.jclinepi.2011.07.011}

\bibitem{Whitehead2015}
Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size
  for a pilot randomised trial to minimise the overall trial sample size for
  the external pilot and main trial for a continuous outcome variable. {\it
  Statistical Methods in Medical Research} 2015.
\newblock \href {\doibase 10.1177/0962280215588241} {doi:
  10.1177/0962280215588241}

\bibitem{Cocks2013}
Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: a
  confidence interval√Ç approach. {\it Journal of Clinical Epidemiology}
  2013\string; 66(2)\string: 197 - 201.
\newblock \href {\doibase http://dx.doi.org/10.1016/j.jclinepi.2012.09.002}
  {doi: http://dx.doi.org/10.1016/j.jclinepi.2012.09.002}

\bibitem{Lee2014}
Lee E, Whitehead A, Jacques R, Julious S. The statistical interpretation of
  pilot trials: should significance thresholds be reconsidered?. {\it BMC
  Medical Research Methodology} 2014\string; 14(1)\string: 41.
\newblock \href {\doibase 10.1186/1471-2288-14-41} {doi:
  10.1186/1471-2288-14-41}

\bibitem{Senn2007}
Senn S, Bretz F. Power and sample size when multiple endpoints are considered.
  {\it Pharmaceut. Statist.} 2007\string; 6(3)\string: 161--170.
\newblock \href {\doibase 10.1002/pst.301} {doi: 10.1002/pst.301}

\bibitem{Chuang-Stein2007}
Chuang-Stein C, Stryszak P, Dmitrienko A, Offen W. Challenge of multiple
  co-primary endpoints: a new approach. {\it Statistics in Medicine}
  2007\string; 26(6)\string: 1181--1192.
\newblock \href {\doibase 10.1002/sim.2604} {doi: 10.1002/sim.2604}

\bibitem{Conaway1996}
Conaway MR, Petroni GR. Designs for Phase {II} Trials Allowing for a Trade-Off
  between Response and Toxicity. {\it Biometrics} 1996\string; 52(4)\string:
  pp. 1375-1386.

\bibitem{Thall2008}
Thall PF. Some geometric methods for constructing decision criteria based on
  two-dimensional parameters. {\it Journal of Statistical Planning and
  Inference} 2008\string; 138(2)\string: 516--527.
\newblock \href {\doibase 10.1016/j.jspi.2007.06.013} {doi:
  10.1016/j.jspi.2007.06.013}

\bibitem{Wilson2015}
Wilson DT, Walwyn RE, Brown J, Farrin AJ, Brown SR. Statistical challenges in
  assessing potential efficacy of complex interventions in pilot or feasibility
  studies. {\it Statistical Methods in Medical Research} 2015\string;
  25(3)\string: 997--1009.
\newblock \href {\doibase 10.1177/0962280215589507} {doi:
  10.1177/0962280215589507}

\bibitem{Deb2002}
Deb K, Pratap A, Agarwal S, Meyarivan T. A fast and elitist multiobjective
  genetic algorithm: {NSGA}-{II}. {\it {IEEE} Transactions on Evolutionary
  Computation} 2002\string; 6(2)\string: 182--197.
\newblock \href {\doibase 10.1109/4235.996017} {doi: 10.1109/4235.996017}

\bibitem{Mersmann2014}
Mersmann O. {\it mco: Multiple Criteria Optimization Algorithms and Related
  Functions}.  2014.
\newblock R package version 1.0-15.1.

\bibitem{Sargent2001}
Sargent DJ, Chan V, Goldberg RM. A Three-Outcome Design for Phase {II} Clinical
  Trials. {\it Controlled Clinical Trials} 2001\string; 22(2)\string: 117 -
  125.
\newblock \href {\doibase http://dx.doi.org/10.1016/S0197-2456(00)00115-X}
  {doi: http://dx.doi.org/10.1016/S0197-2456(00)00115-X}

\bibitem{Hong2007}
Hong S, Wang Y. A three-outcome design for randomized comparative phase {II}
  clinical trials. {\it Statist. Med.} 2007\string; 26(19)\string: 3525--3534.
\newblock \href {\doibase 10.1002/sim.2824} {doi: 10.1002/sim.2824}

\bibitem{Landau2013}
Landau S, Stahl D. Sample size and power calculations for medical studies by
  simulation when closed form expressions are not available. {\it Statistical
  Methods in Medical Research} 2013\string; 22(3)\string: 324-345.
\newblock \href {\doibase 10.1177/0962280212439578} {doi:
  10.1177/0962280212439578}

\bibitem{Jones2001}
Jones DR. A Taxonomy of Global Optimization Methods Based on Response Surfaces.
  {\it Journal of Global Optimization} 2001\string; 21(4)\string: 345-383.
\newblock \href {\doibase 10.1023/A:1012771025575} {doi:
  10.1023/A:1012771025575}

\end{thebibliography}
